Pursuant to 10 CFR 110.70(b)(2) “Public notice of receipt of an application,” please take notice that the Nuclear Regulatory Commission has received the following request to amend an export license. Copies of the request are available electronically through ADAMS and can be accessed through the Public Electronic Reading Room (PERR) link <http://www.nrc.gov/NRC/ADAMS/index.html> at the NRC Homepage.
A request for a hearing or petition for leave to intervene may be filed within 30 days after publication of this notice in the Federal Register. Any request for hearing or petition for leave to intervene shall be served by the requestor or petitioner upon the applicant, the Office of the General Counsel, U.S. Nuclear Regulatory Commission, Washington DC 20555; the Secretary, U.S. Nuclear Regulatory Commission, Washington, DC 20555; and the Executive Secretary, U.S. Department of State, Washington, DC 20520.
In its review of the request to amend a license to export special nuclear material noticed herein, the Commission does not evaluate the health, safety or environmental effects in the recipient nation of the material to be exported. The information concerning this amendment request follows. Start Printed Page 53628
|Description of material||End use||Country of destination|
|Material type||Total qty|
|Name of Applicant Date Application: Transnuclear, Inc., July 18, 2002 Date Received, Application Number, Docket Number: July 18, 2002, XSNM03060/02, 11005070||Highly-Enriched Uranium (93.60%)||Total quantity of HEU authorized for export remains unchanged||To revise schedule & quantity of HEU authorized for export each calendar year for the MAPLE Reactors and to extend expiration date to 12/31/07. HEU used to produce medical radioisotopes||Canada.|
For the Nuclear Regulatory Commission.
Dated: Dated this 9th day of August 2002 at Rockville, Maryland.
Edward T. Baker,
Deputy Director, Office of International Programs.
[FR Doc. 02-20842 Filed 8-15-02; 8:45 am]
BILLING CODE 7590-01-P